Cite
HARVARD Citation
Bargas, S. et al. (2022). An impressive response with larotrectinib in a patient with a papillary thyroid carcinoma harboring an SQSTM1-NTRK1 fusion. European journal of endocrinology. 186 (4), pp. K5-K8. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bargas, S. et al. (2022). An impressive response with larotrectinib in a patient with a papillary thyroid carcinoma harboring an SQSTM1-NTRK1 fusion. European journal of endocrinology. 186 (4), pp. K5-K8. [Online].